Cargando…
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma
PURPOSE: Alveolar soft part sarcoma (ASPS) is a rare, highly vascular tumor with few treatment options. We designed a phase II randomized trial to determine the activity and tolerability of single-agent cediranib or sunitinib in patients with advanced metastatic ASPS. PATIENTS AND METHODS: Patients...
Autores principales: | Nguyen, James, Takebe, Naoko, Kummar, Shivaani, Razak, Albiruni, Chawla, Sant P., George, Suzanne, Patel, Shreyaskumar R., Keohan, Mary Louise, Movva, Sujana, O'Sullivan Coyne, Geraldine, Do, Khanh, Juwara, Lamin, Augustine, Brooke, Steinberg, Seth M., Kuhlmann, Laura, Ivy, S. Percy, Doroshow, James H., Chen, Alice P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068440/ https://www.ncbi.nlm.nih.gov/pubmed/36302173 http://dx.doi.org/10.1158/1078-0432.CCR-22-2145 |
Ejemplares similares
-
Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas
por: O'Sullivan Coyne, Geraldine, et al.
Publicado: (2022) -
A Phase I Study of Ganetespib and Ziv‐Aflibercept in Patients with Advanced Carcinomas and Sarcomas
por: Meehan, Robert, et al.
Publicado: (2018) -
Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer
por: Gopinathan, Ganga, et al.
Publicado: (2022) -
Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial
por: Lee, Jung-Min, et al.
Publicado: (2022) -
Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas
por: Coyne, Geraldine O'Sullivan, et al.
Publicado: (2020)